metabolic disorders

The collaboration between Eli Lilly and Company and KeyBioscience will focus on developing a potential new class of treatments for metabolic disorders, such as type 2 diabetes, called dual amylin calcitonin receptor agonists (DACRAs) more

12 Jun 2017 10:50 News

Swiss pharmaceutical company, Dipharma, has successfully developed a new fast dissolving formulation of carglumic acid tablets that are stable at room temperature. more

4 May 2017 12:30 News